Minervax

Minervax

Engaged in clinical development of a Group B Streptococcal vaccine targeting pregnant women for the prevention of life-threatening infections in newborns.

HQ location
Hellerup, Denmark
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.